Liabilities in USD of Cell Source, Inc. from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Cell Source, Inc. quarterly Liabilities history and change rate from Q4 2014 to Q3 2024.
  • Cell Source, Inc. Liabilities for the quarter ending 30 Sep 2024 was $19.2M, a 18% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Cell Source, Inc. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.2M +$2.93M +18% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $17.7M +$2.44M +15.9% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 $16.8M +$2.38M +16.5% 31 Mar 2024 10-Q 29 Jul 2024
Q4 2023 $15.8M +$2.76M +21.2% 31 Dec 2023 10-Q 14 Nov 2024
Q3 2023 $16.3M +$3.96M +32.2% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $15.3M +$4.5M +41.6% 30 Jun 2023 10-Q 19 Sep 2023
Q1 2023 $14.5M +$4.18M +40.7% 31 Mar 2023 10-Q 23 Aug 2023
Q4 2022 $13M +$2.9M +28.6% 31 Dec 2022 10-K 24 Jun 2024
Q3 2022 $12.3M 30 Sep 2022 10-Q 08 Dec 2022
Q2 2022 $10.8M +$476K +4.6% 30 Jun 2022 10-Q 02 Dec 2022
Q1 2022 $10.3M +$916K +9.79% 31 Mar 2022 10-Q 02 Nov 2022
Q4 2021 $10.1M +$1.74M +20.7% 31 Dec 2021 10-K 08 Aug 2023
Q2 2021 $10.3M +$3.73M +56.4% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $9.36M +$2.97M +46.5% 31 Mar 2021 10-Q 17 May 2021
Q4 2020 $8.4M +$2.54M +43.4% 31 Dec 2020 10-Q 12 Aug 2021
Q3 2020 $7.23M +$1.24M +20.6% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $6.61M +$1.38M +26.3% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $6.39M +$1.22M +23.6% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $5.86M +$871K +17.5% 31 Dec 2019 10-K 15 Apr 2021
Q3 2019 $5.99M 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $5.23M 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $5.17M 31 Mar 2019 10-Q 20 May 2019
Q4 2018 $4.99M -$103K -2.03% 31 Dec 2018 10-K 30 Mar 2020
Q4 2017 $5.09M -$1.37M -21.2% 31 Dec 2017 10-K 01 Apr 2019
Q4 2016 $6.45M +$481K +8.05% 31 Dec 2016 10-K 25 Jul 2018
Q3 2016 $8.09M 30 Sep 2016 10-Q 18 Nov 2016
Q2 2016 $7.48M 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $6.96M 31 Mar 2016 10-Q 13 May 2016
Q4 2015 $5.97M +$2.07M +52.9% 31 Dec 2015 10-K 25 Jul 2018
Q4 2014 $3.91M 31 Dec 2014 10-K 14 Apr 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.